Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas PAZNTIS: A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minues Pazopanib NSC 737754, IND 118613
Randomized Phase II Trial Evaluation the Addition of the IGF-1R Monoclonal Antibody Receptor Ganitumab to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and
Safety of Defibrotide vs Best Supportive Care in the Prevention of
Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Undergoing Hematopoietic Stem Cell Transplant
A Multicenter, Randomized, Placebo-controlled, Double-blind Study of DCC-3014 to Assess the Efficacy and Safety in Patients with Tenosynovial Giant Cell Tumor
Phase II Trial of XL184 Cabozantinib an Oral Small-Molecule Inhibitor of Multiple
Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
A Phase I/II Open-Label Trial of CPI-613� devimistat plus Hydroxychloroquine to Evaluate Maximally Tolerated Dose MTD, Safety and Efficacy in Patients with Relapsed or Refractory Clear Cell Sarcoma CCS